Johanna Repits (Former)
1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency.
(
- Contribution to journal › Letter
- 2011
-
Mark
Reply to Redd et al
(
- Contribution to journal › Letter
- 2010
-
Mark
Increased sensitivity to neutralizing antibodies of end-stage disease R5 HIV-1 is concomitant with reduced gp120 glycosylation and increased plus charge
(
- Contribution to journal › Published meeting abstract
-
Mark
Microbial Translocation Correlates with the Severity of Both HIV-1 and HIV-2 Infections
(
- Contribution to journal › Article
- 2009
-
Mark
Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections
(
- Contribution to journal › Article
-
Mark
Mode of Coreceptor Use by R5 HIV Type 1 Correlates with Disease Stage: A Study of Paired Plasma and Cerebrospinal Fluid Isolates.
(
- Contribution to journal › Article
- 2008
-
Mark
Co-evolution of the HIV-1 R5 phenotype and the viral envelope glycoproteins
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-I variants emerging during AIDS progression
(
- Contribution to journal › Article
-
Mark
Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
(
- Contribution to journal › Article
- 2005
-
Mark
Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency.
(
- Contribution to journal › Article